Roble Belko & Company’s Xperi XPER Stock Holding History

Roble Belko & Company’s Portfolio XPER Stock Details XPER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-220	Closed	-$2K	–	456
2024 Q4	$2K	Hold	220	–	–	﹤0.01%	316
2024 Q3	$2K	Buy	+220	New	+$1.81K	﹤0.01%	297

Other funds holding XPER

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Roble Belko & Company's XPER Position: Q1 2025 in Review

Roble Belko & Company sold out of Xperi (XPER) in Q1 2025, closing a stake of 220 shares — an estimated $2K sold.

Roble Belko & Company first reported a position in XPER in Q3 2024 and held it in 2 quarters. The position peaked at $2K in Q4 2024. 149 funds tracked by Wall St. Rank hold XPER as of Q1 2025.

Roble Belko & Company reported no remaining Xperi position as of Q1 2025 after selling out during the quarter.
Roble Belko & Company sold 220 Xperi shares in Q1 2025, an estimated $2K.
Roble Belko & Company first reported a position in Xperi in Q3 2024 and held it in 2 quarters.
Roble Belko & Company's Xperi position peaked at $2K in Q4 2024.
149 funds tracked by Wall St. Rank held Xperi as of Q1 2025.

Based on Roble Belko & Company's 13F filing for Q1 2025, filed 8 May 2025.